109 related articles for article (PubMed ID: 10694810)
1. Improved safety and titre of murine leukaemia virus (MLV)-based retroviral vectors.
Zhao Y; Low W; Collins MK
Gene Ther; 2000 Feb; 7(4):300-5. PubMed ID: 10694810
[TBL] [Abstract][Full Text] [Related]
2. High efficiency retroviral vectors that contain no viral coding sequences.
Yu SS; Kim JM; Kim S
Gene Ther; 2000 May; 7(9):797-804. PubMed ID: 10822307
[TBL] [Abstract][Full Text] [Related]
3. Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors.
Hlavaty J; Schittmayer M; Stracke A; Jandl G; Knapp E; Felber BK; Salmons B; Günzburg WH; Renner M
Virology; 2005 Oct; 341(1):1-11. PubMed ID: 16054668
[TBL] [Abstract][Full Text] [Related]
4. A murine leukemia virus derived retroviral vector with a rat VL30 packaging psi sequence.
Torrent C; Wang P; Darlix JL
Bone Marrow Transplant; 1992; 9 Suppl 1():143-7. PubMed ID: 1324044
[TBL] [Abstract][Full Text] [Related]
5. Role of a heterologous retroviral transport element in the development of genetic complementation assay for mouse mammary tumor virus (MMTV) replication.
Rizvi TA; Ali J; Phillip PS; Ghazawi A; Jayanth P; Mustafa F
Virology; 2009 Mar; 385(2):464-72. PubMed ID: 19157480
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an internal ribosomal entry segment within the 5' leader of avian reticuloendotheliosis virus type A RNA and development of novel MLV-REV-based retroviral vectors.
López-Lastra M; Gabus C; Darlix JL
Hum Gene Ther; 1997 Nov; 8(16):1855-65. PubMed ID: 9382952
[TBL] [Abstract][Full Text] [Related]
7. Engineering the splice acceptor for improved gene expression and viral titer in an MLV-based retroviral vector.
Lee JT; Yu SS; Han E; Kim S; Kim S
Gene Ther; 2004 Jan; 11(1):94-9. PubMed ID: 14681702
[TBL] [Abstract][Full Text] [Related]
8. MuLV packaging systems as models for estimating/measuring retrovirus recombination frequency.
Patience C; Takeuch Y; Cosset FL; Weiss RA
Dev Biol (Basel); 2001; 106():169-79; discussion 253-63. PubMed ID: 11761229
[TBL] [Abstract][Full Text] [Related]
9. Specific packaging of spliced retroviral vector transcripts lacking the Psi-region.
Pambalk K; Hohenadl C; Salmons B; Günzburg WH; Renner M
Biochem Biophys Res Commun; 2002 Apr; 293(1):239-46. PubMed ID: 12054590
[TBL] [Abstract][Full Text] [Related]
10. The nucleocapsid domain is responsible for the ability of spleen necrosis virus (SNV) Gag polyprotein to package both SNV and murine leukemia virus RNA.
Certo JL; Kabdulov TO; Paulson ML; Anderson JA; Hu WS
J Virol; 1999 Nov; 73(11):9170-7. PubMed ID: 10516024
[TBL] [Abstract][Full Text] [Related]
11. Capsid-targeted viral inactivation can eliminate the production of infectious murine leukemia virus in vitro.
VanBrocklin M; Federspiel MJ
Virology; 2000 Feb; 267(1):111-23. PubMed ID: 10648188
[TBL] [Abstract][Full Text] [Related]
12. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
Sena-Esteves M; Hampl JA; Camp SM; Breakefield XO
J Gene Med; 2002; 4(3):229-39. PubMed ID: 12112640
[TBL] [Abstract][Full Text] [Related]
13. The potential of retroviral vectors to cotransfer human endogenous retroviruses (HERVs) from human packaging cell lines.
Zeilfelder U; Frank O; Sparacio S; Schön U; Bosch V; Seifarth W; Leib-Mösch C
Gene; 2007 Apr; 390(1-2):175-9. PubMed ID: 17045761
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies on cellular gene regulation by HIV-1 based vectors: implications for quality control of vector production.
Zhao Y; Azam S; Thorpe R
Gene Ther; 2005 Feb; 12(4):311-9. PubMed ID: 15550925
[TBL] [Abstract][Full Text] [Related]
15. Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors.
Pizzato M; Merten OW; Blair ED; Takeuchi Y
Gene Ther; 2001 May; 8(10):737-45. PubMed ID: 11420637
[TBL] [Abstract][Full Text] [Related]
16. Construction of retroviral vectors with enhanced efficiency of transgene expression.
Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
[TBL] [Abstract][Full Text] [Related]
17. WPRE-mediated enhancement of gene expression is promoter and cell line specific.
Klein R; Ruttkowski B; Knapp E; Salmons B; Günzburg WH; Hohenadl C
Gene; 2006 May; 372():153-61. PubMed ID: 16488559
[TBL] [Abstract][Full Text] [Related]
18. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
Yu SS; Han E; Hong Y; Lee JT; Kim S; Kim S
Gene Ther; 2003 Apr; 10(8):706-11. PubMed ID: 12692599
[TBL] [Abstract][Full Text] [Related]
19. Complementarity between RNA dimerization elements favors formation of functional heterozygous murine leukemia viruses.
Rasmussen S; Pedersen FS
Virology; 2004 Nov; 329(2):440-53. PubMed ID: 15518822
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of MLV-based retroviral vectors using real-time RT-PCR.
Carmo M; Peixoto C; Coroadinha AS; Alves PM; Cruz PE; Carrondo MJ
J Virol Methods; 2004 Aug; 119(2):115-9. PubMed ID: 15158592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
